|
ALGS Aligos Therapeutics Inc 1799448 |
| Balance Sheet |
|
Current Assets
|
79,822,000 |
|
Assets
|
88,426,000 |
|
Current Liabilities
|
20,956,000 |
|
Liabilities
|
38,330,000 |
|
Equity
|
50,096,000 |
|
Shares Out
|
3,072,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-62,340,000 |
|
Investing Cash Flow
|
-38,251,000 |
| Market Analysis |
Market Cap
|
46,284,670 |
|
Price
|
11.91 |
|
BVPS
|
16.31 |
|
PB
|
0.71 |
|
EPS
|
-25.99 |
|
PS
|
9.26 |
|
FCF
|
-100,591,000 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/31 |
|
11/6 |
-3.07 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALGS documents filed with the SEC.
ALGS Filings
Clear
